Literature DB >> 7634148

Corneal topographic changes induced by pterygia.

M A Pavilack1, B L Halpern.   

Abstract

BACKGROUND: This study characterizes the topographic changes induced by pterygia.
METHODS: Using data obtained from a videokeratoscope (TMS-1), we assessed the topographic changes of corneas from 24 consecutive eyes with pterygia.
RESULTS: Each pterygium induced a localized area of flattening central to its apex of 38.00 +/- 2.80 diopter (D) which was significantly flatter (p < .0001) than the mean corneal power (43.70 +/- 1.70), minimum corneal power (MinK, 42.70 +/- 2.10), and the power of the flattest corneal meridian (42.90 +/- 1.90).
CONCLUSIONS: Our topographic findings characterize an area of localized corneal flattening central to the apex of pterygia. It is not known if this pterygium-associated corneal flattening influences the centripetal growth of pterygia or their tendency not to cross the visual axis.

Entities:  

Mesh:

Year:  1995        PMID: 7634148     DOI: 10.3928/1081-597X-19950301-07

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  3 in total

1.  Prospective study of exclusive strontium-/yttrium-90 beta-irradiation of primary and recurrent pterygia with no prior surgical excision. Clinical outcome of long-term follow-up.

Authors:  Iraklis Vastardis; Bojan Pajic; Richard H Greiner; Brigitte Pajic-Eggspuehler; Daniel M Aebersold
Journal:  Strahlenther Onkol       Date:  2009-12       Impact factor: 3.621

2.  Myopic regression and recurrent Salzmann nodule degeneration after laser in situ keratomileusis in Ehlers Danlos Syndrome.

Authors:  Grant C Hopping; Anisha N Somani; Uma Vaidyanathan; Harry Liu; James R Barnes; Yasmyne C Ronquillo; Phillip C Hoopes; Majid Moshirfar
Journal:  Am J Ophthalmol Case Rep       Date:  2020-05-04

3.  Low-dose strontium-90 irradiation is effective in preventing the recurrence of pterygia: a ten-year study.

Authors:  Xue-jiao Qin; Hong-mei Chen; Liang Guo; Yong-yuan Guo
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.